Provided by Tiger Trade Technology Pte. Ltd.

BIODLINK-B

3.815
+0.1153.11%
Volume:426.80K
Turnover:1.60M
Market Cap:2.95B
PE:-27.56
High:3.855
Open:3.685
Low:3.655
Close:3.700
52wk High:5.870
52wk Low:1.700
Shares:773.00M
HK Float Shares:772.79M
Volume Ratio:1.39
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.138
ROE:-24.21%
ROA:-6.74%
PB:4.10
PE(LYR):-27.56
PS:5.00

Loading ...

China's BioDlink International HY Revenue Falls

Reuters
·
Sep 29

Biodlink International Posts 49.7% Drop in H1 2026 Revenue as CDMO Pivot Accelerates

Bulletin Express
·
Sep 29

Biodlink International Co H1 Revenue RMB 246.011 Million

THOMSON REUTERS
·
Sep 29

BioDlink International (SEHK:1875) Stock Rebound Meets Shrinking Revenue And Fresh Losses

Simply Wall St.
·
Aug 23

BIODLINK-B Posts Interim Results with Total Revenue of RMB 246 Million, CDMO Segment Surges While Proprietary Pipeline Accelerates Global Expansion

Stock News
·
Aug 21

TOT Biopharm FY26 H1 Net Loss Swings to RMB 59 Million; Revenue Drops 49.7% to RMB 246 Million

Reuters
·
Aug 21

BioDlink Announces New Corporate Logo, Affirms No Impact on Shareholder Rights or Operations

Bulletin Express
·
Aug 11

BioDlink posts stable share base in July 2026; outstanding shares remain at 772.79 million

Bulletin Express
·
Aug 05

TOT Biopharm Schedules Board Meeting to Review Interim Results

Reuters
·
Jul 10

BIODLINK-B Keeps Share Capital Steady in June; Confirms 25% Public Float Compliance

Bulletin Express
·
Jul 03

TOT Biopharm Shareholders Approve All AGM Resolutions by Poll

Reuters
·
Jun 26

BIODLINK-B Announces Appointment of Fang Yuan as Joint Company Secretary

Stock News
·
Jun 26

BIODLINK-B and WUXI XDC Forge Service Pact for Antibody Process Development and Production

Stock News
·
Jun 17

Biodlink International Co - to Deliver Ten Batches of Monoclonal Antibody Intermediates to WuXi Biologics

THOMSON REUTERS
·
Jun 17

Biodlink International Co - Aggregate Fee for Services Is RMB19.0 Mln

THOMSON REUTERS
·
Jun 17

Biodlink International Co - Enters Process Development and Manufacturing Services Agreement With WuXi Biologics

THOMSON REUTERS
·
Jun 17

BioDlink International (BIODLINK-B) Secures Shareholder Approval for Three-Year CDMO Pact with WuXi XDC

Bulletin Express
·
Jun 11

BioDlink to Seek 20% Issuance Mandate, 10% Buy-back Capacity and Auditor Switch to Deloitte at 26 June AGM

Bulletin Express
·
Jun 04

BIODLINK-B Proposes Appointment of Deloitte as New Auditor

Stock News
·
Jun 04

TOT Biopharm proposes Deloitte as new auditor as PwC retires

Reuters
·
Jun 04